Raymond James Ups DaVita (DVA) To “Strong Buy”; First Midwest Bank Trust Division Trimmed Its Travelers Companies (TRV) Holding

December 7, 2017 - By Vivian Currie

Among 12 analysts covering DaVita (NYSE:DVA), 1 have Buy rating, 3 Sell and 8 Hold. Therefore 8% are positive. DaVita has $83 highest and $57.0 lowest target. $65.75’s average target is -4.99% below currents

$69.2 stock price. DaVita had 29 analyst reports since August 6, 2015 according to SRatingsIntel. The firm earned “Neutral” rating on Tuesday, December 13 by Robert W. Baird. KeyBanc Capital Markets maintained the stock with “Hold” rating in Monday, November 13 report. The company was upgraded on Tuesday, September 20 by Raymond James. RBC Capital Markets maintained it with “Sector Perform” rating and $83 target in Thursday, August 6 report. The stock of DaVita Inc. (NYSE:DVA) earned “Underweight” rating by JP Morgan on Monday, October 9. Jefferies maintained the shares of DVA in report on Thursday, November 2 with “Hold” rating. RBC Capital Markets maintained the shares of DVA in report on Monday, June 26 with “Hold” rating. Bank of America maintained the stock with “Neutral” rating in Wednesday, November 8 report. Raymond James maintained DaVita Inc. (NYSE:DVA) on Tuesday, November 28 with “Buy” rating. As per Tuesday, August 9, the company rating was maintained by JP Morgan.

First Midwest Bank Trust Division decreased Travelers Companies Inc (TRV) stake by 50.73% reported in 2017Q2 SEC filing. First Midwest Bank Trust Division sold 10,645 shares as Travelers Companies Inc (TRV)’s stock declined 0.95%. The First Midwest Bank Trust Division holds 10,338 shares with $1.31 million value, down from 20,983 last quarter. Travelers Companies Inc now has $37.05 billion valuation. The stock increased 0.03% or $0.04 during the last trading session, reaching $135.36. About 1.04 million shares traded. The Travelers Companies, Inc. (NYSE:TRV) has risen 9.71% since December 7, 2016 and is uptrending. It has underperformed by 6.99% the S&P500.

First Midwest Bank Trust Division increased Visa Inc (NYSE:V) stake by 12,130 shares to 41,823 valued at $3.92 million in 2017Q2. It also upped Intuit (NASDAQ:INTU) stake by 6,760 shares and now owns 11,923 shares. Target Corp (NYSE:TGT) was raised too.

Among 16 analysts covering Travelers (NYSE:TRV), 6 have Buy rating, 3 Sell and 7 Hold. Therefore 38% are positive. Travelers had 46 analyst reports since July 22, 2015 according to SRatingsIntel. On Monday, December 12 the stock rating was upgraded by BMO Capital Markets to “Outperform”. The rating was maintained by UBS on Tuesday, September 19 with “Neutral”. The firm earned “Sell” rating on Tuesday, January 10 by Goldman Sachs. RBC Capital Markets maintained the stock with “Outperform” rating in Friday, July 22 report. The firm has “Hold” rating by Keefe Bruyette & Woods given on Thursday, August 17. The firm has “Neutral” rating by UBS given on Wednesday, November 1. Atlantic Securities downgraded The Travelers Companies, Inc. (NYSE:TRV) on Friday, January 6 to “Underweight” rating. As per Monday, September 25, the company rating was maintained by RBC Capital Markets. The firm earned “Buy” rating on Monday, June 26 by RBC Capital Markets. The rating was maintained by Citigroup with “Buy” on Monday, October 2.

Analysts await The Travelers Companies, Inc. (NYSE:TRV) to report earnings on January, 23. They expect $2.16 EPS, down 32.50% or $1.04 from last year’s $3.2 per share. TRV’s profit will be $591.18M for 15.67 P/E if the $2.16 EPS becomes a reality. After $0.91 actual EPS reported by The Travelers Companies, Inc. for the previous quarter, Wall Street now forecasts 137.36% EPS growth.

The stock increased 13.57% or $8.27 during the last trading session, reaching $69.2. About 9.75M shares traded or 300.57% up from the average. DaVita Inc. (NYSE:DVA) has declined 16.51% since December 7, 2016 and is downtrending. It has underperformed by 33.21% the S&P500.

Analysts await DaVita Inc. (NYSE:DVA) to report earnings on February, 15. They expect $0.91 EPS, down 7.14% or $0.07 from last year’s $0.98 per share. DVA’s profit will be $166.84M for 19.01 P/E if the $0.91 EPS becomes a reality. After $0.81 actual EPS reported by DaVita Inc. for the previous quarter, Wall Street now forecasts 12.35% EPS growth.

Since June 13, 2017, it had 0 buys, and 1 insider sale for $123,665 activity. JIGANTI JEANINE MARIE had sold 1,886 shares worth $123,665.

Investors sentiment increased to 1.08 in 2017 Q2. Its up 0.05, from 1.03 in 2017Q1. It improved, as 48 investors sold DaVita Inc. shares while 135 reduced holdings. 60 funds opened positions while 137 raised stakes. 157.19 million shares or 0.09% more from 157.04 million shares in 2017Q1 were reported. Founders Capital Management Lc owns 93,824 shares or 3.03% of their US portfolio. Millennium Limited Liability Company accumulated 1.04 million shares. Financial Bank Of Montreal Can holds 0.03% or 405,982 shares in its portfolio. Tudor Inv Et Al invested in 0.02% or 8,425 shares. Moreover, Robeco Institutional Asset Management Bv has 0.26% invested in DaVita Inc. (NYSE:DVA). Dekabank Deutsche Girozentrale, Germany-based fund reported 206,858 shares. Inv House Ltd invested 0.24% in DaVita Inc. (NYSE:DVA). Brinker Capital invested 0.03% in DaVita Inc. (NYSE:DVA). Sg Americas Securities Lc invested in 23,448 shares. 24 are owned by Finance. Jensen Mgmt Incorporated accumulated 9,740 shares. Pointstate Capital Limited Partnership has invested 0.58% in DaVita Inc. (NYSE:DVA). Federated Pa has invested 0.01% in DaVita Inc. (NYSE:DVA). Numeric Invsts Ltd Llc has 20,200 shares. Bancorp Of Hawaii accumulated 9,871 shares.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease . The company has market cap of $12.69 billion. It operates through two divisions, DaVita Kidney Care and DaVita Medical Group. It has a 10.54 P/E ratio. The firm operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.

By

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

>